Farms.com Home   News

Research Shows how Historic Landscapes Shape Biodiversity and its Protection

Research Shows how Historic Landscapes Shape Biodiversity and its Protection

By Alistair Keely

Researchers have shown how historic estates, such as Castle Howard and Duncombe Park, have helped shape biodiversity and the role they continue to play in the protection of nature.

The  used —specifically Historic Landscape Characterization data—to examine historic landscapes within protected areas like National Parks and Areas of Outstanding Natural Beauty. The research shows how historic patterns of land use have shaped the landscapes in Britain protected for biodiversity.

Areas in the analysis included the Howardian Hills, North York Moors, Yorkshire Dales and Nidderdale along with 10 National Nature Reserves and 190 Sites of Special Scientific Interest across North Yorkshire. Historic houses and estates with popular nature attractions like Castle Howard, Duncombe Park and Nunnington Hall were also included in the study.

At Duncombe Park, for example, a medieval deer  became a designed  for a stately home which maintained that woodland. This long management history is, in greater part, responsible for it now being a nationally important haven for beetles and other insects, while in other locations woodland has been dramatically reduced or cleared altogether.

Influence

Dr. Michael Stratigos, from the University of York's Leverhulme Center for Anthropocene Biodiversity who led the research, said, "We found that protected areas favor locations with character derived primarily from changes in land-use that occurred in the 18th and 19th centuries. How those historic changes shaped biodiversity should form a priority for research moving forward.

"The  to the influence that large estates have had, which has implications for protected area management and access to natural spaces. Large estates, like Castle Howard and many other privately owned estates, had in the past and continue in the present, to be responsible for much of the most valued biodiversity in England."

Targets

Dr. Stratigos said, "At COP15 in Montreal, the ambition to protect 30% of the globe by 2030 has been in negotiation. To meet these ambitions, the expansion of existing protected areas and the designation of new protected areas should take greater consideration of the types of historic landscape being designated to improve the protected area network."

The research suggests that if similar types of historic landscapes are designated to meet 30x30 targets, similar outcomes and results can be expected in terms of biodiversity in protected areas.

Protection

Dr. Stratigos added: "Estate landscapes have often maintained certain management regimes over long periods of time resulting in highly-valued biodiversity. For example, patches of semi-natural ancient woodland were incorporated into the landscape designs of 18th and 19th-century country houses which have been maintained to this day."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.